State Street Corp Hcw Biologics Inc. Transaction History
State Street Corp
- $2.47 Trillion
- Q4 2024
A detailed history of State Street Corp transactions in Hcw Biologics Inc. stock. As of the latest transaction made, State Street Corp holds 21,446 shares of HCWB stock, worth $145,403. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,446
Previous 21,446
-0.0%
Holding current value
$145,403
Previous $11,000
18.18%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding HCWB
# of Institutions
19Shares Held
3.15MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY2.02MShares$13.7 Million0.01% of portfolio
-
Avantax Planning Partners, Inc.280KShares$1.9 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA243KShares$1.65 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA182KShares$1.23 Million0.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL181KShares$1.23 Million0.0% of portfolio
About HCW Biologics Inc.
- Ticker HCWB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,833,100
- Market Cap $243M
- Description
- HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...